292 related articles for article (PubMed ID: 29166517)
61. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors.
Katsumata M; Ezoe K
J Dermatol; 1990 May; 17(5):307-11. PubMed ID: 2166096
[TBL] [Abstract][Full Text] [Related]
62. Nevus Sebaceous of the Scalp With Stepwise Progression Into Invasive Syringocystadenocarcinoma Papilliferum.
Kneitz H; Goebeler M; Rütten A
Am J Dermatopathol; 2021 Dec; 43(12):965-969. PubMed ID: 34797792
[TBL] [Abstract][Full Text] [Related]
63. Niemann-Pick disease in association with syringocystadenoma papilliferum.
Louri N; Darwish A; Alkhalifa K
Pediatr Dermatol; 2009; 26(6):766-7. PubMed ID: 20199469
[TBL] [Abstract][Full Text] [Related]
64. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature].
Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A
Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666
[TBL] [Abstract][Full Text] [Related]
65. Syringocystadenoma papilliferum in the right lower abdomen: a case report and review of literature.
Xu D; Bi T; Lan H; Yu W; Wang W; Cao F; Jin K
Onco Targets Ther; 2013; 6():233-6. PubMed ID: 23569386
[TBL] [Abstract][Full Text] [Related]
66. Tubular Apocrine Adenoma in Association with an Apocrine Hidrocystoma.
Raven ML; Krivochenitser RI; Lucarelli MJ
Ophthalmology; 2016 Nov; 123(11):2385. PubMed ID: 27772650
[No Abstract] [Full Text] [Related]
67. Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges.
Wan L; Park A; Khachemoune A
Arch Dermatol Res; 2024 Jun; 316(7):421. PubMed ID: 38904691
[TBL] [Abstract][Full Text] [Related]
68. Syringocystadenoma papilliferum of the cervix presenting as vulvar growth in an adolescent girl.
Abak B; Gole P; Dongre A; Kharkar V; Jain S
Clin Exp Dermatol; 2019 Jan; 44(1):58-61. PubMed ID: 30417408
[TBL] [Abstract][Full Text] [Related]
69. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components.
Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H
J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472
[No Abstract] [Full Text] [Related]
70. Trichoblastoma, syringocystadenoma papilliferum, desmoplastic trichilemmoma and tumor of the follicular infundibulum with signet-ring cells, all arising in nevus sebaceus.
Dore E; Noe MH; Swick BL
J Cutan Pathol; 2015 Sep; 42(9):645-51. PubMed ID: 25761672
[TBL] [Abstract][Full Text] [Related]
71. Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal.
Lee CK; Jang KT; Cho YS
J Laryngol Otol; 2005 Dec; 119(12):1004-6. PubMed ID: 16354370
[TBL] [Abstract][Full Text] [Related]
72. Syringocystadenoma papilliferum on the mons pubis.
Suzuki S; Al-Hajjaj S; Lee M; Bhawan J
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906013
[TBL] [Abstract][Full Text] [Related]
73. Apocrine acrosyringeal keratosis in association with syringocystoadenoma papilliferum.
Kishimoto S; Wakabayashi S; Yamamoto M; Noda Y; Takenaka H; Yasuno H
Br J Dermatol; 2000 Mar; 142(3):543-7. PubMed ID: 10735969
[TBL] [Abstract][Full Text] [Related]
74. Unusual congenital syringocystadenoma papilliferum on the scalp presenting as only erosion at birth.
Sho Y; Sakai T; Yamate T; Nakamura Y; Saito-Shono T; Shimada H; Takeo N; Uehara M; Shimizu F; Nishida H; Hatano Y
Eur J Dermatol; 2020 Apr; 30(2):198-199. PubMed ID: 32538363
[No Abstract] [Full Text] [Related]
75. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
Blind A; Weingertner N; Cribier B
Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
[TBL] [Abstract][Full Text] [Related]
76. Basal cell carcinoma, syringocystadenoma papilliferum, trichilemmoma, and sebaceoma arising within a nevus sebaceus associated with pigmented nevi.
Wang Y; Bu WB; Chen H; Zhang ML; Zeng XS; Zhao L; Fang F
Dermatol Surg; 2011 Dec; 37(12):1806-10. PubMed ID: 22093024
[No Abstract] [Full Text] [Related]
77. Poromas with large lumens histopathologically mimicking syringocystadenoma papilliferum: Report of three cases.
Arakawa H; Tanese K; Miura K; Ebata S; Yamada D; Masui Y; Tanaka M; Saida T; Ansai SI
Australas J Dermatol; 2019 Feb; 60(1):e51-e55. PubMed ID: 29943807
[TBL] [Abstract][Full Text] [Related]
78. [Syringocystadenoma papilliferum].
El Makrini NI; Kissou A; Benzekri L; Senouci K; Hassam B
Presse Med; 2019 Nov; 48(11 Pt 1):1349-1350. PubMed ID: 31732362
[No Abstract] [Full Text] [Related]
79. Contiguous squamous proliferations in syringocystadenoma papilliferum: A retrospective study of 14 cases.
Aggarwal D; Chatterjee D; Keshavamurthy V; Chhikara K; Saikia UN; Radotra BD; De D; Singh MP
Indian J Dermatol Venereol Leprol; 2023; 89(2):266-273. PubMed ID: 34623039
[TBL] [Abstract][Full Text] [Related]
80. Tubular apocrine adenoma.
Toribio J; Zulaica A; Peteiro C
J Cutan Pathol; 1987 Apr; 14(2):114-7. PubMed ID: 3036918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
